title: Antibiotics prescription for indigent patients in primary care.
abstract: OBJECTIVE
  A drug use evaluation focusing on prescribed antibiotics among Greek indigent and Social Security patients.
  
  
  METHODS
  Four hundred and forty-six indigent patients insured by Social Care and 332 patients insured under Social Security Funds were interviewed and their prescription records reviewed.
  
  
  RESULTS
  Although 88.5% of indigent patients stated that they had received instructions on antibiotic use and had understood these instructions, only 45.9% could correctly repeat these instructions. Only 9.9% read the enclosed leaflets and 59.4% reported asking the pharmacist for advice, 54.1% of these patients were unaware of the dosage of their medication, and the length of treatment was only written in 13% of cases. The most common diseases among indigent patients were respiratory infection (11.7%) and dental problems (10.1%). The latter ranked 11th among the insured patients (3.7%). Tuberculosis (3.3%) was still one of the most common diseases among the indigent patients. Overall, 30.9% of the prescribed daily defined dose (DDD) of medication for the indigent patients were for cardiovascular drugs (16.9% of the cost), 19.5% were for nervous system drugs (8.9% of the cost), 13.5% for gastrointestinal tract drugs (14.1% of the cost) and only 4.3% were antibiotics (but 16.9% of the cost). The most frequently prescribed antimicrobials were penicillins (45.6%), cephalosporins (19.7%), macrolides (12.6%) and quinolones (9.6%). Antituberculous agents made up 13.7% of the antibiotic prescriptions. The most widely prescribed antibiotics were amoxycillin + clavulanate (19.3%), amoxycillin (7.9%), cefaclor (5.6%), clarythromycin (5.1%) and rifampicin + isoniazid (6.3%).
  
  
  CONCLUSIONS
  The present study emphasizes the need for more information on drug use among indigent patients and their information needs.
authors.affiliation: Department of Pharmacy Services, Chania General Hospital St George, Crete, Greece.
authors.forename: L
authors.initials: L
authors.lastname: Tzimis
authors.forename: N
authors.initials: N
authors.lastname: Katsantonis
authors.forename: A
authors.initials: A
authors.lastname: Leledaki
authors.forename: K
authors.initials: K
authors.lastname: Vasilomanolakis
authors.forename: A
authors.initials: A
authors.lastname: Kafatos
mesh_terms: D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000191:economics*; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D004346:Drug Information Services; D011307:Drug Prescriptions / Q000191:economics* / Q000706:statistics & numerical data*; D004363:Drug Utilization; D005260:Female; D006115:Greece; D006801:Humans; D007407:Interviews as Topic; D008297:Male; D008875:Middle Aged; D010353:Patient Education as Topic; D011203:Poverty
chemical_list: D000900:Anti-Bacterial Agents